Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mary Kate Kasler"'
Publikováno v:
Asia-Pacific Journal of Oncology Nursing, Vol 8, Iss 1, Pp 18-24 (2021)
Objective: Older adults with cancer (OAC) may be at elevated risk for immune-related adverse events (irAEs) during immune checkpoint inhibitor (ICI) therapy due to the normal organ function changes of aging, as well as related to a higher prevalence
Externí odkaz:
https://doaj.org/article/1eac4cb72a5941a7907bd953b55e1d35
Publikováno v:
Asia-Pacific Journal of Oncology Nursing, Vol 4, Iss 2, Pp 127-135 (2017)
Cancer survival rates are generally increasing in the United States. These trends have been partially attributed to improvement in therapeutic strategies. Cancer immunotherapy is an example of one of the newer strategies used to fight cancer, which p
Externí odkaz:
https://doaj.org/article/9143c126cd89418694894d5e6f5cf951
Publikováno v:
Asia-Pacific Journal of Oncology Nursing
Asia-Pacific Journal of Oncology Nursing, Vol 8, Iss 1, Pp 18-24 (2021)
Asia-Pacific Journal of Oncology Nursing, Vol 8, Iss 1, Pp 18-24 (2021)
Objective: Older adults with cancer (OAC) may be at elevated risk for immune-related adverse events (irAEs) during immune checkpoint inhibitor (ICI) therapy due to the normal organ function changes of aging, as well as related to a higher prevalence
Autor:
Neil H. Segal, David M. Hyman, Katherine Kargus, Alison M. Schram, Jessica Flynn, Komal Jhaveri, Mrinal M. Gounder, Danny N. Khalil, Alexander Drilon, Stefan Hamaway, Mary Kate Kasler, Dazhi Liu, Sandy Badson, Natalie M. Blauvelt, Maya Gambarin-Gelwan, Sebastian Mondaca, Bob T. Li, Marinela Capanu, Margaret K. Callahan, James J. Harding
Publikováno v:
Cancer
Background Data on drug-induced liver injury (DILI) and acute liver failure (ALF) in modern phase 1 oncology trials are limited, specifically with respect to the incidence and resolution of DILI and the safety of drug rechallenge. Methods This study
Autor:
RuthAnn Gordon, Mary Kate Kasler
Publikováno v:
Seminars in oncology nursing. 35(5)
Autor:
Mimma Errante, Ruth-Ann Gordon, Kathryn Ciccolini, Anna Skripnik Lucas, Pam Raasch, Mary Kate Kasler, Yelena Shames, Erica Fischer-Cartlidge, Kristen Stasi
Publikováno v:
Clinical journal of oncology nursing. 21
Background Immunotherapy, specifically the use of checkpoint inhibitors, offers patients with cancer an alternative to chemotherapy, targeting different pathways to destroy cancer cells. The side effects of immunotherapies, as well as their impact on
Autor:
Mary Kate Kasler, Kathleen Madden
Publikováno v:
Seminars in Oncology Nursing. 35:150932
Objective To provide a synopsis of immune checkpoint inhibition in solid tumors with a focus on lung cancer and melanoma for the oncology nurse. Data Sources A literature search was conducted from 2012 to the present using key search terms including: